Glen Harbor Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $376K | Buy |
7,196
+560
| +8% | +$29.3K | 0.01% | 807 |
|
|
2019
Q2 | $321K | Buy |
6,636
+84
| +1% | +$4.06K | 0.01% | 863 |
|
|
2019
Q1 | $331K | Hold |
6,552
| – | – | 0.01% | 833 |
|
|
2018
Q4 | $388K | Buy |
6,552
+28
| +0.4% | +$1.66K | 0.01% | 711 |
|
|
2018
Q3 | $429K | Buy |
6,524
+28
| +0.4% | +$1.84K | 0.01% | 781 |
|
|
2018
Q2 | $328K | Hold |
6,496
| – | – | 0.01% | 805 |
|
|
2018
Q1 | $342K | Buy |
6,496
+812
| +14% | +$42.8K | 0.01% | 777 |
|
|
2017
Q4 | $264K | Buy |
5,684
+980
| +21% | +$45.5K | 0.01% | 883 |
|
|
2017
Q3 | $190K | Buy |
4,704
+1,316
| +39% | +$53.2K | ﹤0.01% | 925 |
|
|
2017
Q2 | $115K | Buy |
3,388
+1,708
| +102% | +$58K | ﹤0.01% | 1049 |
|
|
2017
Q1 | $49K | Sell |
1,680
-1,624
| -49% | -$47.4K | ﹤0.01% | 1128 |
|
|
2016
Q4 | $109K | Buy |
+3,304
| New | +$109K | ﹤0.01% | 879 |
|